Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank92
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P92
Near historical high
vs 2Y Ago
2.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 39.63% |
| Q2 2025 | -42.10% |
| Q1 2025 | -15.99% |
| Q4 2024 | -2.63% |
| Q3 2024 | -8.58% |
| Q2 2024 | -39.93% |
| Q1 2024 | 55.50% |
| Q4 2023 | -143.93% |
| Q3 2023 | 15.97% |
| Q2 2023 | 9.95% |
| Q1 2023 | 23.71% |
| Q4 2022 | 0.18% |
| Q3 2022 | -6.60% |
| Q2 2022 | -2.76% |
| Q1 2022 | 34.14% |
| Q4 2021 | -2220.93% |
| Q3 2021 | 88.77% |
| Q2 2021 | -194.89% |
| Q1 2021 | 23.82% |
| Q4 2020 | -114.57% |
| Q3 2020 | -15.28% |
| Q2 2020 | 31.99% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q4 2016 | 0.00% |